Shocking Recall: Magic Mushroom Candies Linked to Severe Illnesses in 20 States – Are You at Risk?

In a sweeping recall operation, Diamond Shruumz-brand magic mushroom-infused candies have been pulled from shelves following reports of severe illnesses in consumers across the United States. The recall includes all flavors of the brand’s product lines, such as microdosing chocolate bars, infused cones, and both micro-dose and mega-dose/extreme gummies. According to the U.S. Food and Drug Administration (FDA), this action was prompted by 39 reported cases of illness spanning 20 states, including at least one case in Nevada. Alarmingly, 23 of those affected have been hospitalized, highlighting the gravity of the situation.

Prophet Premium Blends, LLC, the company behind the affected products, has identified muscimol—a compound found in certain mushroom species—as the potential culprit behind these adverse reactions. Symptoms reported include seizures, respiratory failure, hallucinations, uncontrolled movements, and various cardiovascular issues like abnormal heart rates and blood pressure fluctuations, as reported by News 3 Las Vegas.

The FDA, alongside the Centers for Disease Control (CDC) and various state and local partners, is deeply involved in investigations to determine the exact cause of these incidents. Retail outlets, including smoke and vape shops as well as sellers of hemp-derived products, are being scrutinized for their distribution of these now-recalled items. Notably, the Diamond Shruumz brand has marketed their products as microdosing solutions aimed at enhancing creativity, mood, and focus without inducing full psychedelic experiences.

Testing of the recalled products revealed the presence of several psychoactive substances in two flavors of Diamond Shruumz chocolate bars. Among these substances is 4-acetoxy-N,N-dimethyltryptamine (also known as 4-acetoxy-DMT or psilacetin). The FDA’s official advisory stresses the ongoing nature of the investigation and urges consumers to dispose of any Diamond Shruumz products they may have purchased. Retailers have been advised to cease the sale or distribution of these products until further notice.

This recall serves as a stark reminder of the potential health risks associated with consuming unregulated or improperly tested psychoactive substances. As investigations continue and new information emerges, the priority remains the health and safety of consumers nationwide. The FDA’s swift response underscores the urgent need for stricter regulations and rigorous testing standards to ensure that products reaching the market are safe for consumption.

Consumers are advised to stay informed and exercise caution when purchasing psychoactive products. The incident with Diamond Shruumz underscores the critical importance of regulatory oversight in the burgeoning market for psychoactive and hemp-derived products.

Do you believe stricter regulations and testing standards should be enforced for psychoactive products?